Journal
New England Journal of Medicine
Publication Date
7-25-2024
Volume
391
Issue
4
First Page
320
Last Page
333
Document Type
Open Access Publication
DOI
10.1056/NEJMoa2312948
Rights and Permissions
Litzow MR, Sun Z, Mattison RJ, Paietta EM, Roberts KG, Zhang Y, Racevskis J, Lazarus HM, Rowe JM, Arber DA, Wieduwilt MJ, Liedtke M, Bergeron J, Wood BL, Zhao Y, Wu G, Chang TC, Zhang W, Pratz KW, Dinner SN, Frey N, Gore SD, Bhatnagar B, Atallah EL, Uy GL, Jeyakumar D, Lin TL, Willman CL, DeAngelo DJ, Patel SB, Elliott MA, Advani AS, Tzachanis D, Vachhani P, Bhave RR, Sharon E, Little RF, Erba HP, Stone RM, Luger SM, Mullighan CG, Tallman MS. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. N Engl J Med. 2024 Jul 25;391(4):320-333. doi: 10.1056/NEJMoa2312948. Copyright © 2024 Massachusetts Medical Society. Reprinted with permission.
Recommended Citation
Litzow, Mark R; Uy, Geoffrey L; and et al., "Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults." New England Journal of Medicine. 391, 4. 320 - 333. (2024).
https://digitalcommons.wustl.edu/oa_4/4903
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
